Developer docs
API playgroundTry for free, no card

Search company profiles

Exactmer

Full company profile

uuid000r4uk

Namestring
Exactmer
Legal namestring
Exactmer
Websiteurl
exactmer.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Exactmer is a UK-based deep tech spinout, headquartered in Dagenham and founded in 2018, specializing in advanced polymer synthesis with two distinct product platforms. Its core technology is PLIMs (Polymer Membranes with Locked Intrinsic Microporosity), a new class of ultrathin polymer membranes that selectively separate complex hydrocarbon mixtures with up to 10x higher permeance than existing state-of-the-art membranes while maintaining high selectivity. In validated testing with Arabian Extra Light crude oil alongside SINOPEC, the technology achieved 99.8% heavy hydrocarbon removal and 93% reduction in sulphur-containing compounds, offering an energy-efficient alternative to conventional thermal distillation in oil refining.

The company is extending its polymer chemistry capabilities into a second platform: high purity bio-based solvents for pharmaceutical manufacturing, developed through a UK consortium funded by an Innovate UK grant of over £7 million, targeting at least 60% greenhouse gas emission reduction versus conventional solvent production. Exactmer operates a B2B licensing and co-development model, distributing technology through direct enterprise partnerships and consortium-based collaborations rather than traditional product sales channels. Its GTM motion is enterprise field sales targeting oil & gas and pharmaceutical manufacturing verticals, supported by roll-to-roll manufacturing demonstrated for industrial deployment.

Leadership combines academic research pedigree with emerging commercial discipline: co-founders Andrew Livingston (CEO) and Piers Gaffney (CSO) anchor the scientific platform, while Cristina Bertulli serves as VP of Business Development and Operations. The company is supported by multiple UK university research partnerships and has secured non-dilutive funding from both the EIC Accelerator and Innovate UK, positioning it as an early-stage but well-capitalized deep tech venture advancing sustainable industrial chemistry.

Short descriptiontext

Exactmer is a UK deep tech spinout developing PLIMs polymer membranes for energy-efficient hydrocarbon separation and bio-based solvents for low-carbon pharmaceutical manufacturing, serving oil & gas and pharmaceutical enterprises through licensing and consortium partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDagenham, United Kingdom
HQ citystring
Dagenham
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
polymer membranes, hydrocarbon separation, oligonucleotide synthesis, bio-based solvents, membrane technology
Industry2 codes
PRIMARYIMAEAAAE
Bulk Industrial Solvents
SECONDARYIMAMALAC
Bio-based Polymers & Resins (PLA, PHA, bio-PE, bio-PET, cellulose acetate)
NAICS code2 codes
  • Chemical Manufacturing325
  • All Other Basic Organic Chemical Manufacturing325199
SIC code2 codes
  • Industrial Organic Chemicals2860
  • Miscellaneous Chemical Products2890
Product category
Industrial Membrane Technology
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Membrane Technology Licensing
TypeLicensing Royalties
Description

Licensing of proprietary PLIMs membrane technology for hydrocarbon processing applications in oil & gas industry.

miragenews.com
2Bio-based Solvents Technology
TypeLicensing Royalties
Description

Technology development and industrialization of low-greenhouse gas solvents for pharmaceutical manufacturing through consortium partnerships.

erm.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Exactmer develops and manufactures PLIMs (Polymer Membranes with Locked Intrinsic Microporosity), ultrathin polymer membranes for rapidly and selectively separating complex hydrocarbon mixtures as an energy-efficient alternative to thermal distillation in crude oil refining. The company is also industrializing high-purity bio-based solvents for pharmaceutical medicines manufacturing through a consortium-led program targeting substantial greenhouse gas emission reductions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Up to 10x higher permeance than existing state-of-the-art membranes while maintaining high selectivity
+3 more records
Product overview1 text field

Exactmer is a UK-based deep tech spinout offering two primary product lines: PLIMs (Polymer Membranes with Locked Intrinsic Microporosity) for energy-efficient hydrocarbon separation in crude oil refining, and high purity bio-based solvents for low-carbon medicines manufacturing. The PLIMs technology provides an alternative to conventional thermal distillation, while the solvents initiative targets significant greenhouse gas reduction in pharmaceutical production through a £7 million Innovate UK-funded consortium.

Product and service2 records
1PLIMs (Polymer Membranes with Locked Intrinsic Microporosity)
CategoryMembrane Separation Technology
Description

Ultrathin polymer membranes with locked intrinsic microporosity capable of rapidly and selectively separating complex hydrocarbon mixtures. Demonstrated up to ten-fold higher permeance than state-of-the-art membranes while maintaining high selectivity, removing 99.8% of heavy hydrocarbons and reducing sulphur-containing compounds by 93%. Aimed at oil and gas companies engaged in crude oil refining and hydrocarbon processing.

2High Purity Bio-Based Solvents
CategoryPharmaceutical Solvents
Description

High purity bio-based solvents developed for medicines manufacturing, designed to reduce greenhouse gas emissions by at least 60% compared to conventional solvents. Being industrialized through a consortium of technology providers, pharmaceutical companies, and research organizations for use in pharmaceutical production.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major Chinese petroleum corporation collaborating with Exactmer on development and testing of PLIMs membrane technology for hydrocarbon processing applications. SINOPEC participated in validation of membrane performance using Arabian Extra Light crude oil.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multiple UK universities collaborating with Exactmer on research and development of membrane technology for hydrocarbon separation. Universities provide research expertise and academic validation for the PLIMs technology development.

3UK Consortium Partners (Technology Providers, Pharmaceutical Companies, Research Organizations)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Technology providers, pharmaceutical companies, and research organizations working together under the Innovate UK-funded consortium to industrialize low-greenhouse gas solvents and validate their use in pharmaceutical production.

erm.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

US-based startup developing advanced thin-film composite membranes for industrial separations, including hydrocarbon and solvent applications. Closest direct emerging competitor to Exactmer's PLIMs membrane approach.

TypeDirect peer
Description

Pioneer in industrial membrane separations for hydrocarbons, gas, and petrochemical processing. Directly comparable as a membrane technology provider targeting refining and chemical industry customers.

TypeEmerging player
Description

Developer of specialty membranes for chemical and petrochemical separations, including hydrocarbon processing. Comparable emerging player focused on membrane-based alternatives to distillation.

4Pall Corporation
TypeBroad incumbent
Description

Danaher-owned industrial filtration and separations major serving oil & gas, chemicals, and pharma. Broad incumbent whose separation technology portfolio overlaps with Exactmer's hydrocarbon and solvent applications.

5Honeywell UOP
TypeBroad incumbent
Description

Global licensor of refining and petrochemical process technologies, including separation and upgrading units. Most likely acquirer profile and direct technology competitor for refinery-scale separation licenses.

TypeBroad incumbent
Description

German specialty chemicals major with membrane and separation technology offerings (e.g., SEPURAN) and a strong bio-based and high-purity chemicals portfolio spanning pharma and industrial applications.

TypeBroad incumbent
Description

World's largest chemical company with extensive solvents, bio-based intermediates, and process technology offerings for pharma and refining customers. Comparable broad incumbent and potential acquirer/partner for bio-based solvents.

TypeBroad incumbent
Description

Belgian specialty chemicals and advanced materials player with bio-based and high-purity solvent offerings serving pharma and industrial customers. Comparable in the bio-based solvents space.

TypeBroad incumbent
Description

French licensor of refining and petrochemical process technologies, including separation and upgrading solutions. Comparable as a refining technology licensor and potential competitor/partner.

10DuPont
TypeBroad incumbent
Description

Major materials and specialty chemicals company with established membrane product lines (e.g., FilmTec, nanofiltration) and bio-based intermediates. Broad incumbent spanning membrane and specialty chemical markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Exactmer

Industrial Membrane Technologyexactmer.com

Exactmer is a UK deep tech spinout developing PLIMs polymer membranes for energy-efficient hydrocarbon separation and bio-based solvents for low-carbon pharmaceutical manufacturing, serving oil & gas and pharmaceutical enterprises through licensing and consortium partnerships.

What Exactmer does

Exactmer is a UK-based deep tech spinout, headquartered in Dagenham and founded in 2018, specializing in advanced polymer synthesis with two distinct product platforms. Its core technology is PLIMs (Polymer Membranes with Locked Intrinsic Microporosity), a new class of ultrathin polymer membranes that selectively separate complex hydrocarbon mixtures with up to 10x higher permeance than existing state-of-the-art membranes while maintaining high selectivity. In validated testing with Arabian Extra Light crude oil alongside SINOPEC, the technology achieved 99.8% heavy hydrocarbon removal and 93% reduction in sulphur-containing compounds, offering an energy-efficient alternative to conventional thermal distillation in oil refining.

The company is extending its polymer chemistry capabilities into a second platform: high purity bio-based solvents for pharmaceutical manufacturing, developed through a UK consortium funded by an Innovate UK grant of over £7 million, targeting at least 60% greenhouse gas emission reduction versus conventional solvent production. Exactmer operates a B2B licensing and co-development model, distributing technology through direct enterprise partnerships and consortium-based collaborations rather than traditional product sales channels. Its GTM motion is enterprise field sales targeting oil & gas and pharmaceutical manufacturing verticals, supported by roll-to-roll manufacturing demonstrated for industrial deployment.

Leadership combines academic research pedigree with emerging commercial discipline: co-founders Andrew Livingston (CEO) and Piers Gaffney (CSO) anchor the scientific platform, while Cristina Bertulli serves as VP of Business Development and Operations. The company is supported by multiple UK university research partnerships and has secured non-dilutive funding from both the EIC Accelerator and Innovate UK, positioning it as an early-stage but well-capitalized deep tech venture advancing sustainable industrial chemistry.

Exactmer firmographics

Firmographics
Name
Exactmer
Legal name
Exactmer
Website
https://exactmer.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Exactmer is a UK deep tech spinout developing PLIMs polymer membranes for energy-efficient hydrocarbon separation and bio-based solvents for low-carbon pharmaceutical manufacturing, serving oil & gas and pharmaceutical enterprises through licensing and consortium partnerships.
Ownership category
akta.pro rank

Exactmer industry classification

Industry
Product category
Industrial Membrane Technology
NAICS
Chemical Manufacturing (325), All Other Basic Organic Chemical Manufacturing (325199)
SIC
Industrial Organic Chemicals (2860), Miscellaneous Chemical Products (2890)
akta.pro industry
PRIMARYIMAEAAAE
Bulk Industrial Solvents
SECONDARYIMAMALAC
Bio-based Polymers & Resins (PLA, PHA, bio-PE, bio-PET, cellulose acetate)

Keywords

  • Polymer membranes
  • Hydrocarbon separation
  • Oligonucleotide synthesis
  • Bio-based solvents
  • Membrane technology

Where Exactmer is headquartered

Location

Headquarters

HQ city
Dagenham
HQ country
United Kingdom
HQ region
Europe

Markets served

Exactmer business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Membrane Technology Licensing: Licensing of proprietary PLIMs membrane technology for hydrocarbon processing applications in oil & gas industry.
  2. Bio-based Solvents Technology: Technology development and industrialization of low-greenhouse gas solvents for pharmaceutical manufacturing through consortium partnerships.

Go-to-market motion1 record

Distribution channels1 record

Exactmer product offering

Product offering

Core offering

Exactmer develops and manufactures PLIMs (Polymer Membranes with Locked Intrinsic Microporosity), ultrathin polymer membranes for rapidly and selectively separating complex hydrocarbon mixtures as an energy-efficient alternative to thermal distillation in crude oil refining. The company is also industrializing high-purity bio-based solvents for pharmaceutical medicines manufacturing through a consortium-led program targeting substantial greenhouse gas emission reductions.

Product overview

Exactmer is a UK-based deep tech spinout offering two primary product lines: PLIMs (Polymer Membranes with Locked Intrinsic Microporosity) for energy-efficient hydrocarbon separation in crude oil refining, and high purity bio-based solvents for low-carbon medicines manufacturing. The PLIMs technology provides an alternative to conventional thermal distillation, while the solvents initiative targets significant greenhouse gas reduction in pharmaceutical production through a £7 million Innovate UK-funded consortium.

Differentiator

Problem solved

Functional benefit

Products and services

  • PLIMs (Polymer Membranes with Locked Intrinsic Microporosity) Ultrathin polymer membranes with locked intrinsic microporosity capable of rapidly and selectively separating complex hydrocarbon mixtures. Demonstrated up to ten-fold higher permeance than state-of-the-art membranes while maintaining high selectivity, removing 99.8% of heavy hydrocarbons and reducing sulphur-containing compounds by 93%. Aimed at oil and gas companies engaged in crude oil refining and hydrocarbon processing.
  • High Purity Bio-Based Solvents High purity bio-based solvents developed for medicines manufacturing, designed to reduce greenhouse gas emissions by at least 60% compared to conventional solvents. Being industrialized through a consortium of technology providers, pharmaceutical companies, and research organizations for use in pharmaceutical production.

Quantifiable outcome

  • Up to 10x higher permeance than existing state-of-the-art membranes while maintaining high selectivity
  • +3 more outcomes

Companies that use Exactmer

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Exactmer technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Exactmer partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • SINOPECcoreStrategic or Co-development PartnerMajor Chinese petroleum corporation collaborating with Exactmer on development and testing of PLIMs membrane technology for hydrocarbon processing applications. SINOPEC participated in validation of membrane performance using Arabian Extra Light crude oil.
  • UK UniversitiescoreStrategic or Co-development PartnerMultiple UK universities collaborating with Exactmer on research and development of membrane technology for hydrocarbon separation. Universities provide research expertise and academic validation for the PLIMs technology development.
  • UK Consortium Partners (Technology Providers, Pharmaceutical Companies, Research Organizations)coreStrategic or Co-development PartnerTechnology providers, pharmaceutical companies, and research organizations working together under the Innovate UK-funded consortium to industrialize low-greenhouse gas solvents and validate their use in pharmaceutical production.

Scale indicators5 records

Recent moves5 records

Expansion highlights6 records

Exactmer competitors and assessment

Company assessment

Emerging players

  • Porifera: US-based startup developing advanced thin-film composite membranes for industrial separations, including hydrocarbon and solvent applications. Closest direct emerging competitor to Exactmer's PLIMs membrane approach.
  • Compact Membrane Systems: Developer of specialty membranes for chemical and petrochemical separations, including hydrocarbon processing. Comparable emerging player focused on membrane-based alternatives to distillation.

Direct peers

  • Membrane Technology and Research (MTR): Pioneer in industrial membrane separations for hydrocarbons, gas, and petrochemical processing. Directly comparable as a membrane technology provider targeting refining and chemical industry customers.

Broad incumbents

  • Pall Corporation: Danaher-owned industrial filtration and separations major serving oil & gas, chemicals, and pharma. Broad incumbent whose separation technology portfolio overlaps with Exactmer's hydrocarbon and solvent applications.
  • Honeywell UOP: Global licensor of refining and petrochemical process technologies, including separation and upgrading units. Most likely acquirer profile and direct technology competitor for refinery-scale separation licenses.
  • Evonik Industries: German specialty chemicals major with membrane and separation technology offerings (e.g., SEPURAN) and a strong bio-based and high-purity chemicals portfolio spanning pharma and industrial applications.
  • BASF: World's largest chemical company with extensive solvents, bio-based intermediates, and process technology offerings for pharma and refining customers. Comparable broad incumbent and potential acquirer/partner for bio-based solvents.
  • Solvay: Belgian specialty chemicals and advanced materials player with bio-based and high-purity solvent offerings serving pharma and industrial customers. Comparable in the bio-based solvents space.
  • Axens: French licensor of refining and petrochemical process technologies, including separation and upgrading solutions. Comparable as a refining technology licensor and potential competitor/partner.
  • DuPont: Major materials and specialty chemicals company with established membrane product lines (e.g., FilmTec, nanofiltration) and bio-based intermediates. Broad incumbent spanning membrane and specialty chemical markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Exactmer social profiles

Digital presence

Exactmer financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Exactmer leadership team

Management profile

Number of profiles

Profiles3 records

Exactmer funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Exactmer M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Exactmer

What does Exactmer do?

Exactmer develops and manufactures PLIMs (Polymer Membranes with Locked Intrinsic Microporosity), ultrathin polymer membranes for rapidly and selectively separating complex hydrocarbon mixtures as an energy-efficient alternative to thermal distillation in crude oil refining. The company is also industrializing high-purity bio-based solvents for pharmaceutical medicines manufacturing through a consortium-led program targeting substantial greenhouse gas emission reductions.

Is Exactmer a public or private company?

Exactmer is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Exactmer founded?

Exactmer was founded in 2017. It employs 11 to 50 people.

Where is Exactmer based?

Exactmer is headquartered in Dagenham, United Kingdom, in the Europe region.

How does Exactmer make money?

Two revenue lines are on record. Membrane Technology Licensing is the primary driver. The others are bio-based Solvents Technology.

Who are Exactmer's main competitors?

Emerging players on record are Porifera and Compact Membrane Systems. Membrane Technology and Research (MTR) is listed as a direct peer. Broad incumbents are Pall Corporation, Honeywell UOP, Evonik Industries, BASF, Solvay, Axens and DuPont.

Does Exactmer have an API?

No public API is recorded for Exactmer.

What industry is Exactmer in?

Exactmer's product category is Industrial Membrane Technology. Its primary akta.pro industry code is IMAEAAAE, Bulk Industrial Solvents, with a secondary code of IMAMALAC, Bio-based Polymers & Resins (PLA, PHA, bio-PE, bio-PET, cellulose acetate). Its NAICS code is 325 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mirage NewsNew Membrane Tech to Slash Energy in Hydrocarbon ProcessingInternational researchers have developed a new class of ultrathin polymer membranes with locked intrinsic microporosity (PLIMs) capable of rapidly and selectively separating complex hydrocarbon mixtures, offering a more energy-efficient alternative to conventional thermal distillation in crude oil refining. The membranes demonstrated up to ten-fold higher permeance than existing state-of-the-art membranes while maintaining high selectivity, removing 99.8% of heavy hydrocarbons and reducing sulphur-containing compounds by 93% in tests with Arabian Extra Light crude oil. The research was led by UK deep tech spinout Exactmer in collaboration with multiple UK universities and SINOPEC, with the team demonstrating scalable manufacturing using roll-to-roll processing for industrial deployment.School of Electronic Engineering and Computer ScienceNew Membrane Technology Could Transform Hydrocarbon Processing by Slashing Energy UseResearchers from Exactmer and Queen Mary University of London developed ultrathin polymer membranes that enable rapid, selective separation of hydrocarbon mixtures with significantly lower energy consumption than traditional distillation. The technology, utilizing polymers of locked intrinsic microporosity, demonstrated high efficiency in removing heavy hydrocarbons and sulfur compounds during tests with crude oil and refinery streams. This scalable innovation offers a potential pathway to reduce carbon emissions and operational costs in the global refining and chemical manufacturing sectors.Celtic-RenewablesUK consortium to help accelerate adoption of low carbon medicines manufacturingA UK consortium led by Exactmer, with GSK support, was awarded over £7 million from Innovate UK and DHSC to produce high-purity bio-based solvents for medicines manufacturing. The 36-month project targets lifecycle greenhouse gas reductions of at least 60% compared to conventional solvents, aiming for global commercial scale by the early 2030s.ERMUK Consortium Advances Low-Carbon Medicines ManufacturingA UK-based consortium led by Exactmer, with strategic support from GSK, has been awarded over £7 million in funding from Innovate UK in partnership with the Department of Health and Social Care to advance the production of high purity bio-based solvents for medicines manufacturing. The 36-month project aims to replace petroleum-derived solvents with bio-based alternatives, targeting at least 60% reduction in lifecycle greenhouse gas emissions compared with conventional solvents. The consortium brings together technology providers, medicines manufacturers, and pharmaceutical companies including GSK, Croda, Cytiva, and CPI, using advanced membrane purification technologies to industrialize cost-effective, low-carbon bio-based solvents.